Osteoporosis Medication and Quality of Life in Older Women - Original Investigation

Abstract

Aim: We aimed to investigate the effect of drug therapy on quality of life in older women with osteoporosis. Material and Methods: One hundred seventy seven women over 65 years were enrolled in this study. Quality of life was evaluated by Short-Form-36 (SF-36). Participants’ quality of life was compared according to their medication use for osteoporosis by comparing Physical Component Summary (PCS) and Mental Component Summary (MCS) score of SF-36 between groups. Results: While one hundred twenty two(68.9%) of the participants had not used any drug, 20 (11.3%) women had used only vitamin D-calcium and, 35 (19.8%) women had used antiresorptive agents plus vitamin D-calcium. There were no statistically difference between groups in respect to age and bone mineral density (p>0.05). The mean values of PCS were 34.80±11.24, 30.33±9.49, and 31.56±7.28 respectively in the groups 1, 2 and 3. The mean values of MCS were 44.91±9, 44.15±11.93, and 44.42±12.09 respectively in the groups 1, 2 and 3. There were no significant differences between the PCS and MCS values (p>0.05, p>0.05). Conclusion: The findings of this study were considered that vitamin D plus calcium and antiresorptive agents were not sufficient to improve the quality of life in the older women with osteoporosis. (From the World of Osteoporosis 2008;14:7-11)

Keywords

• Osteoporosis
• quality of life
• treatment
• elderly